Managing lipids

Use of statins inprimary care and patient adherence to these medicines remains suboptimal. 

 

For consumers, check out
 Statin medicines: frequently asked questions

Managing lipids

Key points

  • Assess absolute cardiovascular risk, using an appropriate risk calculator, before prescribing lipid-modifying medicines
  • Prescribe lipid-modifying medicines for patients with high cardiovascular risk
  • Optimise LDL lowering by adequately trialling statin therapy before adding a second lipid-modifying medicine
  • Recognise that statin intolerance is rarely life-threatening and may have a lower incidence than is commonly reported
  • Systematically assess and manage suspected statin-associated muscle symptoms (SAMS) 

 

Video - NPS MedicineWise Briefing: everything you need to know about statin intolerance

Spend 12 minutes with NPS MedicineWise's Natalie Raffoul for a briefing on the controversial topic of statin intolerance - get the latest evidence and learn about the new NPS statin associated muscle symptom treatment algorithm.

 

Practice review – Managing lipids: statins revisited

Dr holding tablet computer showing 'Statins'

Australian GPs recently received a Practice review on their prescribing of statins and ezetimibe in practice.

  • Find out more about how to interpret your graphs and tables
  • Reflect on your practice and prescription patterns of statins and ezetimibe
  • Review and download a sample report

Read the full details

  • Find out more about how to interpret your graphs and tables
  • Reflect on your practice and prescription patterns of statins and ezetimibe
  • Review and download a sample report
 

Can co-enzyme Q10 supplementation prevent or treat statin-associated muscle symptoms?


    <img src=

Evidence supporting the use of CoQ10 supplements to prevent or treat SAMs in clinical practice is inconsistent.

Review the evidence, and read our expert's opinion about the use of CoQ10 supplementation in cases of SAMs. 

Read the full article.

 

Medicinewise News: Uncovering the truth about statin intolerance


    <img src=

Muscle symptoms are the most commonly reported form of statin intolerance, but are they as common as patients and doctors think? A systematic approach to assessing and managing muscle complaints among patients taking statins may improve both adherence to statins, and patient CV outcomes.

Read the full article.

 

Statins revisited: appropriate patient selection and management are key


    <img src=

The use of statins in primary care remains suboptimal, with evidence suggesting these medicines are being prescribed for patients with elevated cholesterol but low absolute CV risk, and underused by patients with high CV risk. This means that some patients are unnecessarily treated and patients who would benefit from lipid-modifying medicines may not be receiving necessary treatment. 

Read the full article.

 

Statins: benefits still outweigh perceived risks 


    <img src=

Statins remain a foundation of lipid management due to their well-established efficacy at preventing vascular events.1-4 Despite this proven efficacy and safety, use of statins in clinical practice, and adherence to these medicines by patients, is not optimal.

The Statins: optimising therapy, addressing intolerance program emphasises the importance of using an absolute cardiovascular (CV) risk approach to guide treatment decisions and the appropriate use of statin therapy. This program also looks at the current evidence around the true incidence of statin-associated muscle symptoms (SAMS), and provides tools and strategies to help health professionals effectively assess and manage SAMS.

NPS MedicineWise has collaborated with external clinical experts to develop practical resources for health professionals to use with patients with suspected muscle symptoms, including a SAMS assessment guide, a SAMS management algorithm, Statin FAQs for patients and a Statins Patient Action Plan for assessing and managing muscle symptoms.

See the Resources tab in this page for more information.

 

Australian Prescriber: Encouraging adherence to long‑term medication


    <img src=

Tim Usherwood
Aust Prescr 2017;40:147-501

Patients should be asked about adherence at every consultation.

Read the full article here

Learn more about:

  • using a collaborative communication style
  • using the patient’s own expressions and responding to their cues
  • how to normalise non-adherence
  • using open questions and more specific probes.
  • using a collaborative communication style
  • using the patient’s own expressions and responding to their cues
  • how to normalise non-adherence
  • using open questions and more specific probes.